Exelon Forecast, price target & analysts
Exelon Target price 2026 - Analyst rating & recommendation
Exelon Classifications & Recommendation
Exelon Price Target
| Target Price | $48.96 |
| Price | $40.20 |
| Potential | 21.79% |
| Number of Estimates | 20 |
| 20 Analysts have issued a price target Exelon 2027 . The average Exelon target price is $48.96. This is 21.79% higher than the current stock price. The highest price target is $60.90 51.49% , the lowest is $41.41 3.01% . | |
| A rating was issued by 26 analysts: 7 Analysts recommend Exelon to buy, 17 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Exelon stock has an average upside potential 2027 of 21.79% . Most analysts recommend the Exelon stock at Hold. |
Sales and Margin forecast 2026, 2027 to 2030
20 Analysts have issued a sales forecast Exelon 2026 . The average Exelon sales estimate is
This results in the following potential growth metrics:
16 Analysts have issued an Exelon EBITDA forecast 2026. The average Exelon EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
22 Exelon Analysts have issued a net profit forecast 2026. The average Exelon net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
22 Analysts have issued a Exelon forecast for earnings per share. The average Exelon EPS is
This results in the following potential growth metrics and future valuations:
Current Exelon Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Argus Research |
Buy
➜
Buy
|
Unchanged | Sep 22 2026 |
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Sep 18 2026 |
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Aug 21 2026 |
| Truist Securities |
Hold
➜
Hold
|
Unchanged | Aug 13 2026 |
| Truist Securities |
Hold
➜
Hold
|
Unchanged | Jul 16 2026 |
| Truist Securities |
Hold
➜
Hold
|
Unchanged | May 29 2026 |
| TD Cowen |
Hold
➜
Hold
|
Unchanged | May 15 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Argus Research:
Buy
➜
Buy
|
Sep 22 2026 |
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Sep 18 2026 |
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Aug 21 2026 |
|
Unchanged
Truist Securities:
Hold
➜
Hold
|
Aug 13 2026 |
|
Unchanged
Truist Securities:
Hold
➜
Hold
|
Jul 16 2026 |
|
Unchanged
Truist Securities:
Hold
➜
Hold
|
May 29 2026 |
|
Unchanged
TD Cowen:
Hold
➜
Hold
|
May 15 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
